THERMOFORMABLE FIBER-REINFORCED SPLINT MATERIAL

Information

  • Research Project
  • 3493567
  • ApplicationId
    3493567
  • Core Project Number
    R43CA062619
  • Full Project Number
    1R43CA062619-01
  • Serial Number
    62619
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/10/1993 - 30 years ago
  • Project End Date
    5/9/1994 - 30 years ago
  • Program Officer Name
  • Budget Start Date
    9/10/1993 - 30 years ago
  • Budget End Date
    5/9/1994 - 30 years ago
  • Fiscal Year
    1993
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/10/1993 - 30 years ago
Organizations

THERMOFORMABLE FIBER-REINFORCED SPLINT MATERIAL

The objective is to improve the ease, cost, and efficiency of using splints to treat patients with musculoskeletal disorders. Splints are commonly used to treat sprains, fractures, muscle contraction, and spasticity. Low-temperature thermoformable (LTT) in situ to address patient treatment needs. Currently, because of relatively low strength and stiffness. LTT splint materials are only used in low load-bearing applications. High load-bearing splint applications require high- temperature then plastics or thermoset materials. High-temperature thermoplastics cannot be formed in situ and therefore are molded by trail and error to fit to patient. Thermoset materials can be molded in situ, but cannot be reshaped to optimize the fit. These limitations suggest that there is a need for-low-temperature thermoformable material that will mold directly on the patient, reshape to optimize fit, and provide the stiffness and strength required to treat high load-bearing applications. The goal to develop a fiber-reinforced LTT splint material with high strength and rigidity evaluating the strength, stiffness, and thermoformability of various fiber/matrix laminate architectures. The results will determine the feasibility of producing how strength and stiffness fiber-reinforced LTT composite materials and the potential for these materials to be used in clinical splinting applications.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    SIMULA, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    TEMPE
  • Organization State
    AZ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    852835350
  • Organization District
    UNITED STATES